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Animals can be used in many ways in science and scientific research. Given that society values sentient animals
and that basic research is not goal oriented, the question is raised: “Is the use of sentient animals in basic research
justifiable?” We explore this in the context of funding issues, outcomes from basic research, and the position of
society as a whole on using sentient animals in research that is not goal oriented. We conclude that the use of
sentient animals in basic research cannot be justified in light of society’s priorities.
Introduction
The purpose of this paper is to explore the use of senti-
ent animals in basic research. (We realize humans are
animals but will use the word animal to mean nonhu-
man animal in this review.) We ask the question, “Is the
use of sentient animals in basic research justifiable?”
The reason we ask the question this way is that there is
evidence that society has decided that if sentient animals
can be used to predict human response to drugs and
disease, then using them is acceptable. However, such
use is not scientifically tenable, as animals cannot pre-
dict human response [1-27]. (See references 1 and 2 for
reviews that include the theory behind this position and
the empirical evidence supporting it. See references 3-27
for analysis of selected examples. We fully understand
the contentious nature of our statement that animals
cannot predict human response to drugs and disease
but our defense of that statement is in references 1 and
2, not in this paper.) As a result, the questions that arise
are: “What of using sentient animals in research that is
recognized as curiosity-driven rather than goal-oriented?
What factors should be considered when using sentient
animals in such an endeavour? What would an informed
society think justifies the use of sentient animals in
research in general?”
In this essay, we show that: 1) basic research by defini-
tion is not designed to lead to cures; 2) in a vast major-
ity of cases it does not; and 3) we show that society is
not comfortable with this situation. We view this paper
as a syllogism. IF society is not comfortable, or does not
condone, using sentient animals in research that does
not lead to cures and IF basic research is just that kind
of research THEN society does not condone using senti-
ent animals in basic research.
If basic research is defined as research that is not
designed to predict human response to drugs or disease
and is curiosity-driven, then what is purpose of taking
the readers’ time to explore the use of sentient animals
in basic research? Is not the outcome already known? In
reality, the previous points are very contentious, as is
the conclusion, and thus the point of this essay is to
take the reader through the major considerations. The
authors started this discussion along with Niall Shanks
in the article, “Are animal models predictive for
humans?” [1] This essay is part two of our examination
of the issue of using animals in research and in science
in general.
This entire topic is very emotional and contentious
and has many facets. There are many additional ques-
tions that can and eventually should be addressed. For
example:
1. What kind of basic research can be performed
without using animals and what are relative benefits
and costs?
2. What was the role of animals in past scientific
and medical breakthroughs? (This is not an easy
question to answer. The exact history of how break-
throughs and discoveries happened is more similar
to assembling a jigsaw puzzle than a straightforward
example of A led to B led to C.)
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pened without using animals? If such breakthroughs
could not have occurred without animals, during
that particular era in history, why was this the case?
Did advances in science and or engineering subse-
quently occur that would have allowed the discovery
or breakthrough to have been made later without
the use of animals? What would the consequences
have been of a later date for the breakthrough?
4. How are animals used in the totality of research
and science and what are the scientific merits of
these uses? For example, in the review article “Are
animal models predictive for humans?” [1] and the
book Animal Models in Light of Evolution [2] the
authors outline nine ways animals are used in
science and advocate for the position that seven
out of the nine ways are scientifically viable. By
dividing the use of animals into categories, as we
are doing in this essay, the topic is not only made
more manageable but also allows for more preci-
sion in the arguments. Also, sweeping generaliza-
tions are avoided. Scientifically viable use of
animals in one of the nine categories cannot be
used to justify the ways animals are used in other
categories.
5. Should there be a concerted effort by scientists to
explain the value of basic research for knowledge
sake alone? Would the position of society on using
sentient animals in basic research change if society
believed, like many scientists, that research with sen-
tient animals is justified solely on the basis of
achieving more knowledge?
6. What barriers exist to replacing animals in
research? What role do Institutional Review Boards
and Institutional Animal Care and Use Committee
play in this? Do they help or hinder? How available
is human tissue as opposed to animal tissue and
why?
7. What does research about research reveal? It is
the opinion of the authors that society needs much
more research about research. What works and what
does not? What has the highest rate of return? Is
the division between the National Institutes of
Health (NIH) and the National Science Foundation
(NSF) working out as planned or should the process
be changed? What types of research are under
funded and what types are over funded?
8. Last in this list (but this is by no means an
exhaustive list) is the issue of ethics. Can humans
u s ea n i m a l si nw h a t e v e rw a yw es e ef i t ?W h yd o
European counties requires more justification of the
ethical cost:benefit ratio than the US? Are some sen-
tient animals more worthy of consideration than
others?
All of the above are part and parcel of the general
topic of using animals in research and science. As we
did in the essay “A r ea n i m a lm o d e l sp r e d i c t i v ef o r
humans?” [1], in this essay we break the problem down
into one manageable question while acknowledging that
the issue per se is much larger and that this essay is but
one component of many.
Societal Norms
Philosophies of life vary considerably, especially where
using animals in research is concerned. Some hold that
animals should be used regardless of sentience or socie-
tal concerns. Derbyshire is representative of many in the
basic research community when he states:
Ultimately, we cannot have it both ways. It is not
possible to advocate animal welfare and at the same
time give animals untested drugs or diseases, or slice
them open to test a new surgical procedure. The
t h r e eR s[ t h en o t i o nt h a tt h en u m b e ro fa n i m a l s
used should be Reduced, the procedures Refined to
decrease pain, and animals as a whole should ulti-
mately Replaced with nonanimals] encourage a focus
on animal welfare that is both unrealistic and dis-
honest. Regardless of any beliefs about the value of
animals, if you engage in activities that are invasive
or lethal to animals or if you control their reproduc-
tion, their living space and their habits, you are
expressing a de facto belief that animals are suffi-
ciently different from humans to make such activ-
ities justifiable. Scientists are keen to defend
themselves against accusations of cruelty by promot-
ing their allegiance to the three Rs but forget that
the real reason for animal experimentation is to
advance the welfare and understanding of humanity.
Advancing human understanding requires the free-
dom to do more animal research, and often with
higher species, and is incompatible with continued
support for the three Rs [28].
Others hold a different view. A poll conducted by
the Pew Research Center and the American Associa-
tion for the Advancement of Science (AAAS) and
released on July 9, 2009 revealed that only 52% of the
nonscientist general public supported the use of ani-
mals in scientific research [29]. (It should be noted
here that most polls on this subject, like the Pew/
AAAS poll have been of the either or variety: “Do you
support or reject the use of animals in research?”
Such polls have thus not allowed the respondent any
flexibility in the response or any nuance in his posi-
tion. From our perspective these polls are suboptimal
hence should be used as an acknowledged inexact
metric or for tracking purposes. We will not be
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allow for a division of the use of animals in science
and research are needed.) Better polls have asked
more specific questions and have consistently revealed
that society in general condones using animals in
research when they think it will lead to life-saving
treatments but not when they think it curiosity-driven.
For example, in 1999, MORI conducted a poll in asso-
ciation with New Scientist that was published in New
Scientist on May 22, 1999 [30]. When respondents
were asked whether they favored using animals, 24%
answered yes while 64% said no. But the pollsters
then broke the questions down into several categories.
For example, when respondents were questioned
about experiments in which mice would be subject to
pain, illness or surgery, 61% disapproved using them
in order to study how the sense of hearing works, but
only 32% disapproved of using the mice to ensure a
new drug to cure childhood leukemia is safe and
effective. When monkeys were substituted for mice
the disapproval went from 64% to 75% and 32% to
44%, respectively.
The above suggests that more detailed questions
reveal more about society’s attitudes than simple either
or questions. It appears to us that the more informed
society is–vis-à-vis more precise questions–the more
uncomfortable they are over using sentient animals for
non-goal oriented research. Anecdotally, we see the
most discomfort using animals like nonhuman primates,
dogs, and cats–animals that society is ether exposed to
on a daily basis or relates to as being like us. This raises
many questions, one of which is: “How important is cur-
rent biomedical basic research is in leading to
treatments?”
Societies built on the principles of so-called Western
philosophy (the United States, Europe and so forth)
appear to be uncomfortable with sentient animals being
used in basic research; basic being defined as research
not designed to lead to cures. This theme continues
with Giles writing in Nature:
In the contentious world of animal research, one
question surfaces time and again: how useful are ani-
mal experiments as a way to prepare for trials of
medical treatments in humans? T h ei s s u ei sc r u c i a l ,
as public opinion is behind animal research only if it
helps develop better drugs. Consequently, scientists
defending animal experiments insist they are essen-
tial for safe clinical trials, whereas animal-rights acti-
vists vehemently maintain that they are useless [31].
(Emphasis added.)
The Institute for Laboratory Animal Research [[32]a]
and other proponents of using animals in research [33]
have views similar to Giles. An editorial in Nature in
2009 reinforced the above stating: “Animal-research
policies need to be guided by a moral compass–ac o n -
sensus of what people find acceptable and unaccepta-
ble.” [34] It should be noted here that this position is
somewhat at odds with what the late animal cam-
paigner Henry Spira claimed. Spira thought that as
long as society accepted eating a n i m a l sa sm o r a l l y
proper, it would have no problem with experimenting
on them. This is important to our discussion as, in
making his claim, Spira ignored the fact that many of
the founders of the various antivivisection societies ate
meat and that members of antivivisection societies
today do as well. The Nature comment is closer to the
mark–people can be and are inconsistent and some
things bother them more than others. Such is the rea-
lity of life.
Many if not most in our Western society allow that
sentient animals deserve some moral consideration
when discussing their use in research and journals like
Nature acknowledge this. (We realize that society is not
monolithic and that opinions vary on almost all issues
including this one. Nevertheless, judging from polls and
comments in scientific journals it appears that the US
and Europe, at least, are composed of individuals that,
on the whole, are not comfortable with sentient animals
being used in curiosity driven research.) There is a cost:
benefit analysis to be done here–the cost being the suf-
fering of sentient animal–and some in society have per-
formed this analysis and are not comfortable with using
animals in basic research but are comfortable with using
them in other ways. (There is another cost and that is
the relative merit of basic research on the whole, using
animals or not, as opposed to spending our limited
research budget on clinical research or other areas of
research. However, as this is not our topic, we will leave
it for another.) It is this view–the cost:benefit analysis
that values cures but not curiosity-driven research–that
we will assume when discussing animal use for basic
science.
Definitions
Since we are concerned with two concepts, sentience
and basic research, we will take a moment to better
define or describe them. We have already referred to
basic research as being research that is not designed to
lead to cures but we need to lend some support to this
definition. Basic research has also been called basic
science research, curiosity-driven, blue-sky research,
pure research, and fundamental research [32,35-38]. We
will refer to it as basic research. Basic research can be
variously defined and what researchers mean when they
say basic research varies considerably, but the following
definition is representative. The Organisation for
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research is:
Experimental or theoretical work undertaken pri-
marily to acquire new knowledge of phenomena and
observable facts without any particular application
or use in view. It is usually undertaken by scientists
who may set their own agenda and to a large extent
organise their own work [39].
Francis Bacon [40], Claude Bernard[41], and JJ
Thompson[[42], the discoverer of the electron, The
National Environment Research Council [38], Braben
[43], and others [[32]b], [35] agree with the thrust of the
above. Arthur Kornberg stated in an Editorial in Science
in 1995:
We are urged: Do strategic basic research! Do targeted
basic research! How can we make clear the oxymoronic
nature of these terms? [44]
While the above does not ensure that the definition
we are using is universally acceptable, it does make clear
the distinction between applied, goal-oriented research
that, in our view, is synonymous with predictive research
and research that is not,b yi t sn a t u r e ,p r e d i c t i v ef o r
humans.
L e tu sb ev e r yc l e a ro nt h ei m p o r t a n c eo fb a s i c
research in science, historically. Because of basic
research, many of the most important breakthroughs in
physics, chemistry, and biology happened. Basic research
has been very important to scientific advancement.
Discoveries and inventions derived from basic science
research include:
￿ The discovery of DNA
￿ Basic biochemistry, such as the Krebs cycle
￿ The periodic table of the elements




￿ Electrons, protons, and neutrons
￿ Nuclear power
￿ Electromagnetic waves
￿ Induction coils in automobiles
￿ Global Positioning Satellite system
Basic research does not, however, necessarily involve
using sentient animals. Basic research can be conducted
using nonsentient animals, on a computer, in a physics
or chemistry lab, doing thought experiments, or in myr-
iad other ways. Virtually all basic research in chemistry
and physics (that led to the discoveries listed above)
does not involve using sentient animals and many of the
greatest discoveries that reduced the burdens of illness
and disability came from these two fields. For example,
CT scans, PET scans, radiographs, cathode rays, ther-
mionic valves, x-ray crystallography, nuclear magnetic
resonance and MRI scanners, radioactive implants, the
ultracentrifuge, methods for preparing pure enzymes
and viruses, the chemistry of hormones, protein electro-
phoresis, chromatography, electron microscopy, mass
spectroscopy, and many more were all the results of
basic research in physics and chemistry. These discov-
e r i e sa n dt h et e c h n o l o g yr e p r e s e n t e db yt h e s ed i s c o v -
eries have probably gone further to alleviate suffering
than most other breakthroughs.
We are by no means questioning the value of basic
research per se in science in general. (We do discuss the
fact that the relative importance of basic research in the
biomedical sciences is being questioned with regard to
how much money should be directed to it as opposed to
more clinically oriented research.) By definition, any-
thing that leads to more knowledge is valuable if one
values more knowledge. Many argue that any knowledge
gained is worthwhile and no one can deny that even
today knowledge is being gained from using sentient
animals. There are certainly experiments currently con-
ducted on, for example, nonhuman primates for the
purposes of studying neurophysiology that cannot be
performed upon humans. We acknowledge that scienti-
fic knowledge can be and is being advanced by studying
sentient animals in laboratories. This fact is not in dis-
pute in the paper. Rather, we are discussing the neces-
sity or the cost:benefit ratio, as appreciated by society,o f
using sentient animals in such research in the biomedi-
cal sciences.
Basic biological research has traditionally studied life
at the most basic level; what the cell is, what it is made
of, what distinguishes life from nonlife, what everything
is built of and so forth. In applied research, the scien-
tists usually want to make something commercially
viable. There is no doubt that research is a continuum
ranging from basic to applied and it is not always easy
to categorize a specific research project. But, based on
the definitions above, one thing remains certain: Basic
research makes no claims of applicability.
Historically, animal use in research was synonymous
with basic research. It was easy to dissect or vivisect ani-
mals without any particular end in mind. If you were
curious about a phenomenon or wanted to learn more
about life in general, animals could be used. For exam-
ple, Claude Bernard’s research with animals was largely
basic science research. This approach was largely suc-
cessful when scientists wanted to learn the very funda-
mentals of life. After all, monkeys, frogs, mice, and
humans have much in common. But research today and
the practice of medicine today focuses on the differences
between individual humans [45-61] not the
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has implications for our theme.
The second term that needs to be defined is sentience.
Sentient,l i k ebasic research, can be variously defined,
including:
￿ having sense perception;
￿ consciousness;
￿ experiencing sensation or feeling;
￿ responsive to or conscious of sense impressions;
￿ aware;
￿ finely sensitive in perception or feeling;
￿ able to experience physical and possibly emotional
feelings;
￿ having the capacity to receive sensations;
￿ able to perceive.
For the purposes of this paper, exactly which animals
are sentient and which are not is immaterial. Most peo-
ple will agree that dogs, chimpanzees, and mice are sen-
tient while most will also agree that fruit flies, worms,
and members of Cnidarian are not. The controversy we
are addressing is whether society approves of sentient
organisms per se being used in basic research, not
exactly which animals occupy this category. Exactly
which animals are sentient can be discussed after the
concept we are exploring has been settled and indeed is
already being discussed in many books and journals.
The issue of whether sentience confers moral consid-
eration has also been addressed elsewhere and we refer
the reader to those arguments [62-66]. Very briefly,
such arguments state that sentience is the only morally
relevant trait that all current recipients of moral consid-
eration have in common; hence any sentient individual
should be a moral recipient. This is called the argument
for moral consistency. While society per se cannot articu-
late the argument for moral consistency, they certainly
have a sense of the concept.
Julius Comroe and Robert Dripps
Using animals in basic research is a division of basic
research in general. Examining the value of basic
research in biomedical research is a good place to begin
our discussion.
Susan Hockfield, president of the Massachusetts Insti-
tute of Technology, wrote in an editorial for Science:
U.S. federal investments in basic research trans-
formed life and commerce in the 20th century. They
sent us to the Moon and beyond, revolutionized,
helped to feed the planet, reinvented work processes,
and drove the remarkable economic growth of the
post-1950 s era in the United States. These advances
and more grew out of the convergence between
engineering and the early 20th-century discoveries in
the physical sciences. The United States can antici-
pate comparable world-changing innovations in the
21st century if we adapt our education and research
funding strategies to capitalize on new opportunities
emerging at the convergence of the life sciences with
the physical sciences and engineering [67].
Basic research in the United States began in earnest
after World War II. This was due at least in part to the
engineer Vannevar Bush, director of the Office of Scien-
tific Research and Development. Bush wrote a report for
president Roosevelt stating that “new knowledge can be
obtained only through basic scientific research.” [68]
This marked a turning point in research funding. In
the 19th century, most research had been privately
funded, with industrial and government funding increas-
ing in the 20th century. After this report, government
funded research, as opposed to privately funded
research, became the norm. In the 19th century,
research was expected to produce results. Not all did,
and some was funded without such expectations, but
overall the funders expected practical results. As a result
of this report, the US government, in 1950, formed the
National Science Foundation which has funded basic
research ever since. (Today, NIH as well as other gov-
ernment agencies and charities also fund a large amount
of basic research.) This emphasis on basic research
spread across the Atlantic and has been the standard
worldwide ever since.
Has the value of basic research in current-day medi-
cine been proven? Everyone has anecdotes, sometimes
many, to support their view that basic research, espe-
cially basic research using sentient animals, is vital for
medical science to advance. But are there scientific data
to support this view? The current emphasis on basic
research in medicine, as opposed to applied research,
grew out of a U.S. Defense Department study published
in 1967 in Science that concluded that research per-
formed with an end in mind was far more effective in
improving a technology than research performed with
no goal in mind, e.g., basic research [69]. This study led
then-president Johnson to state: “[A] great deal of basic
research [in medicine] has been done ... but I think the
t i m eh a sc o m et oz e r oi no nt h et a r g e t s– by trying to
get our knowledge fully applied ... We must make sure
that no life-saving discovery is locked up in the labora-
tory [70].”
This perceived negative attitude about basic research
led respiratory physiologist Julius Comroe and anesthe-
siologist Robert Dripps to conduct a survey concerning
medical discoveries. The classic justification for basic
research comes from that study published in 1976 [71].
Their paper “Scientific Basis for the Support of
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articles judged to be essential for later clinical advances
in cardiovascular and pulmonary medicine and surgery,
were not clinically oriented at the time they were con-
ducted and that 62 percent of key articles were the
fruits of basic research. This appears to be strong evi-
dence that basic and translational research with animals
is key to finding cures and was in fact seized upon by
other countries. As noted by Grant et al.:
Since that analysis, support for basic research has
increased in the G7 countries. In the UK, Research
Council expenditure on basic research has increased
from a low of £444 million (or 42 per cent of total
civil R&D) in 1991/1992 to £769 million (or 61 per
cent of total civil R&D). Although it would be diffi-
cult to argue that Comroe and Dripps were directly
responsible for a strategic shift (or drift) in the type
of science supported by research funders, their argu-
ments are often cited (albeit at times implicitly) in
support of increased funding for basic biomedical
research [72].
A PubMed search (conducted on August 17, 2010)
revealed 22 citations for the 1976 Comroe-Dripps paper.
We believe this is very significant. Our claim that basic
research, specifically basic research using sentient ani-
mals, is the accepted standard for advancing knowledge
that will eventually be used to develop treatments, is
supported by the paucity of references. The value of
Comroe-Dripps is simply not questioned despite the far-
reaching ramification as noted by Grant et al. above.
Only recently [72] has the conclusion of Comroe-Dripps
begun to be seriously questioned.
At this point in time we begin to see a dichotomy in
how scientists explain the value of basic science research
to society. Because of comments by Johnson and others
and the great advances in applied research, some in the
basic research community began feeling pressure from
society to justify their research on grounds other than
knowledge for knowledge sake. This break from the past
has direct implications for our discussion. Society was
already hinting that there are limits to what it would fund
in terms of knowledge for knowledge sake. It is our con-
tention that much current basic research is done under
the guise of applied research because it increases the likeli-
hood that the project will be funded by a granting institu-
tion [2]. For example, Freeman and St. Johnston in 2008:
Many scientists who work on model organisms,
including both of us, have been known to contrive a
connection to human disease to boost a grant or
paper. It’s fair: after all, the parallels are genuine, but
the connection is often rather indirect [73].
Using animals as causal analogical models [74] or
predictive models is not basic research; it is applied
research. The real crux of the argument for some
seems to be: “Give us money for basic science research
using sentient animals because our research is predic-
tive for humans” [[2]b]. When such research turns out
not to be predictive, however, they state: “Our research
is basic research so it is not supposed to be predic-
tive.” Even those who admit that basic research using
sentient animals is not predictive hide under the
umbrella of “animal models really are predictive” to
increase their likelihood of obtaining grant money [[2]
b].
(We should here point out that we do not believe
the scientist-reader so naïve as to not understand what
we are referring to. We, and we feel sure the scientist-
reader, are very aware that in order to gain funding
from institutions like NIH, the applicant is under pres-
sure to show that the research in question ties in
directly with a human disease [unpublished observa-
tions]. The applicant is under pressure to turn, what
has been considered basic research, into applied
research. The problems with this condition are numer-
ous, nevertheless are not part of our considerations at
present. Suffice it to say we are attempting to use
words and phrases, like basic research,t h a th a v e
meaning consistent with reality as opposed to the
meanings attributed to them in the grant-funding
process.)
Comroe and Dripps were basic research and animal
testing enthusiasts. They had criticized President John-
son’s administration for coming out in favor of applied,
not basic, research. They also criticized the first heart
transplant surgeons for failing to publicly state that the
operation, in their opinion, was only possible secondary
to the use of animals in basic research [71,75-77]. Com-
roe had also written a critique of medical progress stat-
ing that all major discoveries had been a result of basic
research involving animals [76,77]. Comroe was also cri-
tical of clinical research:
Let’s not live in constant fear of the great god Ran-
domization [clinical research], his (or her) appetite is
huge, and, if fed continuously, could consume much
of the nation’s research dollars and personnel, and
even the lives of patients [78].
The above statement is still quoted as a reminder that
many have historically held and still hold clinical
research in disdain. Silverman in 2004:
At the time of the 1969 debate [regarding optimal
oxygen levels in premature babies], I found it hard
to understand why those who spoke against a
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so easily (the power of RCT [randomized con-
trolled trial] format had been firmly and widely
established following the famous clinical trials in
Britain in the 1940 s and 1950s). But I had under-
estimated the influence of the counteroffensive
mounted in the U.S. by prominent laboratory-
oriented researchers. For example, one celebrated
leader wrote ...
Here, Silverman quotes Comroe (the “great god Ran-
domization” quote referenced above) then continues:
These dismissive comments concerning the use of
statistical methods in clinical studies was a reminder
of the disturbing split in outlook about how the
medical profession should go about solving puzzles
that turn up on the wards [79].
Comroe and Dripps surveyed the “scientific commu-
nity” to determine which discoveries were important.
They sent a number of surveys (some have estimated
approximately one-half) to scientists performing basic
science experiments. Not surprisingly, these scientists
concluded that basic science animal studies had been
invaluable. As the then-assistant editor and future editor
of the British Medical Journal pointed out, the report
entirely left out the clinical discovery of the effects of
smoking on heart and lung disease, though this link was
the “most important therapeutic maneuver for most doc-
tors treating lung and heart disorders.” [80] (Emphasis
added.) Clinicians, in all likelihood, would not have left
out that discovery, lending credence to the notion that
Comroe and Dripps favored basic researchers when
sending out their survey.
T h eC o m r o eD r i p p sR e p o r ti ss t i l lc i t e da se s s e n t i a l
by those who wish to justify the use of sentient animals
in basic research. (It has been the authors experience
that these discussions usually occur outside the scienti-
fic literature hence another reason for the low number
of citations for Comroe Dripps.) However, it was (in
1987, Smith questioned their conclusions [80]) and still
is criticized by numerous scientists and clinicians for
faults of methodology and bias. How reliable is the
Comroe-Dripps analysis? Grant et al. observe that due
to methodological flaws, the work by Comroe and
Dripps
... would probably not meet today’ss t a n d a r d sf o r
peer review. As Farrar observed, among the metho-
dological problems “ ... was a lack of clarity over
whose opinions had been surveyed, how clinical
advances were assessed and how a key article was
defined.” [81]
Grant et al. concluded that it takes about 17 years for
basic research to have a clinical impact. More impor-
tantly:
Using the revised bibliometric protocol, we have
shown in this study that ... between 2 per cent and
21 per cent of research was basic. This corroborates
the findings of the clinical guidelines study that
showed ... only 8 per cent of research was basic.
T h e s et w of i n d i n g sa r ea to d d sw i t hC o m r o ea n d
Dripps finding that 40 per cent of all research arti-
cles judged to be essential for later clinical advance
were not clinically oriented at the time of the study,
thus undermining the evidence base that has, in the
past, supported the increased funding of basic
research. [[72]b]
G r a n te ta l .c o n c l u d e dt h a tC o m r o eD r i p p sw a s“not
repeatable, reliable, or valid [82].” Strong words indeed.
Additionally, Grant et al. did not address whether the
basic science breakthroughs that were instrumental and
were made using sentient animals could have been
made without using them. If one is analyzing the impor-
tance of using sentient animals (Grant et al. were not),
this is not an unimportant point.
More recently, others have also questioned the trans-
lation rate of basic research in general into clinically
useful treatments. In 2003, Contopoulos-Ioannidis et al.
quantified the translation rate of “highly promising”
basic research into clinical applications. They published
a study in the American Journal of Medicine that
revealed of 101 basic research papers published in the
high-profile journals Nature, Cell, Science, the Journal of
Biological Chemistry, the Journal of Clinical Investiga-
tion,a n dthe Journal Experimental Medicine between
1979 and 1983, twenty-seven led to randomized clinical
trials and only five eventually gave rise to licensed clini-
cal application [83,84]. They concluded that “[e]ven the
most promising findings of basic research take a long
time to translate into clinical experimentation, and
adoption in clinical practice is rare [83].”
Contopoulos-Ioannidis et al. actually searched all the
articles published in the above-mentioned journals
between 1979 and 1983; a total of around 25,000. Crow-
ley commented on this:
Of the 25,000 articles searched, about 500 (2%) con-
tained some potential claim to future applicability in
humans, about 100 (0.4%) resulted in a clinical trial,
and, according to the authors, only 1 (0.004%) led to
the development of a clinically useful class of drugs
(angiotensin-converting enzyme inhibitors) in the 30
years following their publication of the basic science
finding. They also found that the presence of
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lating a basic finding into a clinical trial by eightfold.
Still, regardless of the study’s limitations, and even if
the authors were to underestimate the frequency of
successful translation into clinical use by 10-fold,
their findings strongly suggest that, as most obser-
vers suspected, the transfer rate of basic research
into clinical use is very low[85]. Emphasis added.
The above casts severe doubt on the value of basic
research in finding treatments and cures.
The Institute for Scientific Information (ISI) studied
citation rates of papers published in journals indexed by
the Institute between 1981 and 1985 and found that
55% of all articles were not cited within five years after
publication [86]. The journals that ISI index are only
the top ranked journals. The articles that appear in the
lower ranked journals are not thought to receive as
many citations as articles that appear in the top ranked
ones. So the 55% figure is probably very high if all jour-
nals were considered. ISI also found that self-citation
accounted for between 5% and 20% of all citations. The
number of journals (science and nonscience) now num-
bers over 108,000 [86].
The actual results from years of rich funding to basic
research is forcing some within the research community
to acknowledge the failure of basic research to deliver
o ni t sp r o m i s e s[ 8 7 ] .D r i v e nl argely by this recognition,
translational medicine has become a more frequent
phrase in medical literature. Ioannidis, writing in the
Journal of Translational Medicine presents a good
example of this mindset: “There is considerable evidence
that the translation rate of major basic science promises
to clinical applications has been inefficient and disap-
pointing [88].”
How is progress measured?
Grant et al. expressed the expectations of funding medi-
cal research when they stated:
The United Kingdom spends over £1600 million a
year on non-commercial biomedical and health ser-
vices research. This research is funded either from
the public purse, such as the NHS and the Medical
Research Council, or medical research charities, such
a st h eW e l l c o m eT r u s t .The tacit understanding is
that the biomedical research these bodies support
will lead to an eventual improvement in health[89].
(Emphasis added.)
Many have questioned, however, if this funding is
being properly directed and are asking for objective cri-
teria for measuring the source of progress in medical
practice [89-93].
Outgoing president Dwight Eisenhower seemed pres-
cient when he warned in his last speech as president
that the military-industrial complex was exerting too
much influence in America’s politics. The phrase mili-
tary-industrial complex (meaning the marriage of the
military with industry in general in order to obtain gov-
ernment money to fund projects the military desires)
has been around ever since and currently most everyone
understands what it means. What has been forgotten
about Eisenhower’s speech that day was that he had a
similar warning about the influence the government had
on scientific research [94]. A similar warning/analysis of
government funded basic research is presented in Nat-
ure 2008:
There is a growing disparity at the heart of biomedi-
cine. In some ways, the field is experiencing a golden
age: the quantity of basic research is shooting off the
charts and budgets are far higher than they were
two decades ago. Yet the impact of this research is
growing at a much more modest rate: new cures and
therapies are ever more expensive to develop and
worryingly thin on the ground [95].
NIH has come under fire for funding basic research
instead of more goal-oriented research [87,96-98]. Huge
strides in basic research are not resulting in correspond-
ing advances in the stated goal of NIH, which is “to
reduce the burdens of illness and disability [99].” From
1998 to 2003, the budget of the National Institutes of
Health doubled. The 2004 budget request was $27.9 bil-
lion. It is estimated that roughly 70% of NIH’s research
budget goes to basic science [97,98]. The percentage in
the UK is about the same [100] and more recent num-
bers suggest the ratio has not changed [101-104].
But despite this infusion of cash, new chemical enti-
ties, the supposed fruits of basic research, went from
having a 14% chance of success upon entering phase 1
trials to having an 8% chance of reaching the market
[103]. Based on the conclusions of Contopoulos-Ioanni-
dis et al [83] and Grant et al. [72] one might question
the large percentage of research funds directed to a
modality the results of which are responsible for such a
small percentage of clinical breakthroughs. Chalmers:
Basic and applied research are both needed to find
ways of protecting health, but the longstanding
imbalance in the funding for these two broad
spheres of biomedical research cannot be defended
in the light of what we know about their relative pay-
back[105]. (Emphasis added.)
In 2003, JAMA published a report prepared by a Clini-
cal Research Roundtable (CCR) at the Institute of
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Academies of Science convened a Clinical Research
Roundtable in 2000 to analyze the success of basic
research. They reported in 2003 that there is a “discon-
nection between the promise of basic science and the
delivery of better health [102].” Rosenberg echoed the
CRR when he called the notion that that the rapid
growth in scientific publications and the increase in
information about disease is resulting in better human
health an “illusion.” [104] The CRR also pointed out
that clinical research receives about half the money that
basic science receives [102], which is consistent with the
70% figure for basic research funding cited above. Simi-
larly, a working group formed by the United Kingdom-
based Academy of Medical Sciences expressed concern
that clinical research, including large clinical trials,
cohort studies, and meta-analyses was being ignored in
favor of laboratory-based research [106].
Ioannidis has questioned the importance of basic
research in resulting in better treatments [107]. Ioanni-
dis addressed animal models and stroke. A study con-
cluded that out of 1026 chemicals tested in animals,
those chosen for clinical trials were not significantly dif-
ferent from the ones not chosen in terms of effect on
infarct size [108]. In other words, the results from ani-
mal studies did not inform the choice for continuing to
clinical trials. Ioannidis then states: “Evidence-based
medicine does not seem to have penetrated basic and
preclinical science, while basic and preclinical research
is often performed in a clinical and methodological
vacuum.” [107]
There is clearly a great divide between the cold assess-
ment of the current basic research paradigm’s delivery
on its promises and the rhetoric aimed at the public and
lawmakers by the animal model community. For exam-
ple, Sigma Xi: “An end to animal research would mean
an end to our best hope for finding treatments that still
elude us.” [109]
Basic research and the use of sentient animals
All of the above must be placed in the context of basic
research using sentient animals. If basic research in the
life sciences is questionable for finding cures, what
about the questionable practice of using sentient ani-
mals in basic research? Rothwell:
In the current difficult financial environment for UK
universities, only substantial increases in funding for
practice-oriented research, preferably with full eco-
n o m i cc o s t i n g ,w i l lp e r s u a d et h e mt ot a k et h e
research needs of the NHS more seriously. The
intellectual and economic cases are strong, and the
potential benefits are huge. Indeed, most major ther-
apeutic developments over the past few decades have
been due to simple clinical innovation coupled with
advances in physics and engineering rather than to
laboratory-based medical research. The clinical ben-
efits of advances in surgery, for example, such as
joint replacement, cataract removal, endoscopic
treatment of gastrointestinal or urological disease,
endovascular interventions (eg, coronary and periph-
eral angioplasty/stenting or coiling of cerebral aneur-
ysms), minimally invasive surgery, and stereotactic
neurosurgery, to name but a few, have been incalcul-
able. Yet only a fraction of non-industry research
funding has been targeted at such clinical innova-
tion. How much more might otherwise have been
achieved? [93] (Emphasis added.)
Rothwell goes on to say that much of the failure of
basic research can be attributed to the use of animal
models. He is not alone. Sydney Brenner who won a
Nobel prize for research on Caenorhabditis elegans
advocated for more research using Homo sapiens and
called Homo sapiens “the model organism.” [110]
Even the media has recognized the disconnect
between basic research and treatments. Sharon Begley,
writing in the Wall Street Journal:
“Patients,” says immunologist Ralph Steinman of
Rockefeller University, New York, “have been too
patient with basic research.”...Many of the brightest
scientists have, therefore, plunged into the minutiae
of roundworm genes and fruit-fly receptors, instead
of human diseases. “Most of our best people work in
lab animals, not people,” says Dr. Steinman, who
presents his case in a recent issue of the journal Cer-
ebrum. “But this has not resulted in cures or even
significantly helped most patients.”... “Human experi-
ments are much more time-consuming and more
difficult than animal studies,” says Rockefeller’s
James Krueger, whose human research includes try-
ing to correlate gene activity and changes in
immune-system cells with the progression of psoria-
sis. “There are also funding issues. It’s much easier
to write a successful grant proposal for animal
experiments. Animals are homogeneous, and let you
say ‘aha!’ in a neat, clean experiment.” Humans, in
contrast, are genetically and behaviorally diverse,
making it hard to tell whether some aspect of their
disease reflects the disease alone, their DNA, how
they live – or some messy permutation of all three
[98].
It is difficult to say what percentage of basic biomedi-
cal research involves sentient animals as rats, birds, and
mice need not be counted in accordance with the Ani-
mal Welfare Act. The best estimate we could find was
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for Biomedical Research, Board on Basic Biology (see
figure 1 [111]). (Despite the NIH’s public funding, more
recent numbers are not readily available). [Table 1]
It appears that, on average greater than or equal to
50% of NIH extramural research dollars went to
research involving sentient animals. According to the
table, at least 45% went to research on mammals (most
people consider mammals sentient and many even con-
sider all vertebrates sentient [112-123]) and another 30%
to research involving nonmammalian vertebrates and so
forth (it appears that most people think at least some of
these animals are sentient). Assuming some of the non-
mammalian vertebrates are sentient, then the total is
easily over 50%. Based on these numbers and NIH’s pre-
disposition to fund basic research, it appears feasible
that at least 50% of extramural funding went to basic
research on sentient animals.
In 1997, it was estimated that between 18 and 22 mil-
lion animals were used in basic biomedical research in
the U.S. and that about 85% of animals used were mice,
rats, and birds [124]. In retrospect, that was probably a
vast underestimate. Regardless, by 2000, this estimate
had grown. A report prepared by the Library of Congress
Federal Research Division estimated that the number of
mice, rats, and birds used annually in the U.S. (in all
areas) was more than 500 million [125]. The exact num-
ber of animals used in research is today, as was the case
in 1997, unknown but the skyrocketing growth in the use
of transgenic and otherwise genetically modified strains
of mice alone suggests that the number must be very
large. Madhusree Mukerjee, a former editor of Scientific
American, stated that over 100 million transgenic mice
were being used as of 2004 [124]. Five hundred million
may in fact be on the low side. Has this apparently very
significant increase in the use of animals yielded signifi-
cant improvements or breakthroughs in the treatment of
human illness? Apparently not. This has implications for
using sentient animals in basic research
Possible Objections
When the above is discussed with basic researchers who
use sentient animals, several objections are forthcoming.
1. Discovering something new is very difficult and to
describe it as “inefficient” implies there is a more
efficient way of doing it. This is false. We must use
animals.
This is fallacious for several reasons. First, just because
something new is discovered does not mean the new
discovery will have any meaning in terms of curing
human disease. New discoveries are made everyday but,
as the above studies report, that does not equate with
new treatments. Second, there are numerous ways of
conducting basic research and research designed to
learn fundamental properties of living organisms such as
humans. Using human tissue seems a very good metho-
dology and has an excellent track record of leading to
more knowledge about humans.
Third, perhaps the most damning analogy of inefficient
basic research that uses sentient animals is the glass bead
game popularized in Herman Hesse’s book of the same
name. Horrobin recently wrote an article about that very
topic including the use of animals to search for knowl-
edge about human drug and disease response.
A wonderful metaphor of much modern medical and
pharmaceutical research can be found in the book
entitled The Glass Bead Game by Herman Hesse. In
this story, the leaders of the real world conspire with
the brightest of scholars to create a magical state
within a state, the isolated world of Castalia. Castalia
recruits the most thoughtful and scholarly youths,
Table 1 Distribution of NIH Support of Extramural
Research Among Humans, Laboratory Mammals, and
Other Research Subjects, Expressed as Percentages of
Total Dollars and of Total Projects and Subprojects
a
Subject Fiscal Year Research
Dollars, %
Extramural Total Projects And
Subprojects, %






















aUnpublished information provided by Division of Research Resources,
National Institutes of Health.
bThis category includes invertebrates, nonmammalian vertebrates, bacteria,
viruses, mathematical and computer simulations, and other subjects.
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that the highest achievement of the human mind is
to play the almost infinitely complicated and subtle
‘glass bead game’, an intellectual Olympics which
challenges and stretches the most exceptional. The
world of the game is beautifully refined and intern-
ally self-consistent. The only problems are that Cas-
talia makes almost no contact with the real world,
and that playing the game makes no contribution to
real world issues [126].
Using sentient animals in basic research makes use of
many resources. Funds that could go elsewhere, and
researchers themselves, are commodities that are
consumed.
Fourth, the question lumps together all kinds of basic
research. Basic research in physics, for example, is hard
and the best way to make new discoveries certainly
appears to be doing basic research in the traditional
way. But this does not imply that discovering new things
about humans can or should be accomplished using
sentient animals in basic research.
A n df i n a l l y ,t h ec l a i mt h a tw ec a n n o td oi ta n yo t h e r
way is like Pascal’s wager. “What do we have to lose by
using animals?” The answer is, we lose what society
would have received from research using the basic
research modalities that do not include sentient animals;
human tissue, in silico research, gene arrays, and so
forth. Based on the above, it appears society has more
to potentially gain from those nonanimal modalities
than from using animals.
2. Your definition of basic research is wrong. Basic
research is goal-oriented.
Based on the definition with which we began this
paper, we respectfully disagree. But if basic research is
synonymous with achieving goals then this points us
back toward using animals as predictive surrogates for
humans. We again direct the reader to a previous paper
[1] and book [2] that address this issue in detail. If by
goal, our critics mean increasing the amount of knowl-
edge on the world, then this is a pointless tautology.
3. Society accepts using sentient animals as food, so
to object to using animals in research is inconsistent.
We touched on this in when we discussed Spira’s
argument but will go into more detail here. The critic
will get no argument from us that society is inconsis-
tent. In fact society has been inconsistent in many ways
in many different times. If society and the government
waited for consistency nothing would ever change. How-
ever, the point we are making is that there are, at times,
things that society, in sufficient numbers, objects to and
is sufficiently disturbed by, that necessitate change
regardless of the other inconsistencies implied by this.
One obvious example is the abolition of slavery in the
Deep South of the U.S. while simultaneously denying
most blacks and women the right to vote. While eradi-
cation of the greater wrong should not be used to allow
perpetuation of a lesser wrong, in fact, this is often the
case. Yet it is equally important to note that the process
of rectification is frequently iterative, and, as such,
occurs as a series of changes over time.
The fact remains that society values certain resources,
and some of those are not even sentient. The yew tree
Taxus brevifolia is but one example. The anticancer
medication Taxol was originally derived from the spe-
cies of yew tree that was endangered and hence led to
much discussion in society as to the value of the tree
and its possible extinction versus using it to treat can-
cer. Robert Holton of Florida State University and Bris-
tol Meyers solved the problem by discovering a way to
use the common yew tree Taxus baccata to obtain a
chemical that could then be modified to the active drug.
Currently, the drug is produced by cell culture.
But prior to these breakthroughs, the issue was so
contentious that the Native Yew Conservation Council
(YewCon) was formed in the 1980’s to address the pro-
blem. Some compared harvesting the endangered tree to
slaughtering the buffalo [127-129]. (For the record, the
authors disagree with the concern that values plants
over cancer patients, but this simply illustrates the fact
that different elements of society value things differently
and that society as a whole may value something that
individual members do not.)
4. Clinical research using humans is also flawed, as,
frequently, the basic principles underlying the dis-
ease in question are not known.
Granted. But this assumes the basic principles can
only be learned from using animals, as opposed to
human tissues.
5. All research builds upon previous research that
used animals; hence animals have been essential in
all discoveries to date.
Fallacious. Just because A preceded B does not mean
A caused B. There is a difference between animals being
necessary for an advance as opposed to merely being
sufficient for that advance. We touched on this when
discussing further questions that need to be addressed.
Moreover, even if animals used in basic research dec-
ades ago proved necessary,i td o e sf o l l o wt h a tt h es a m e
is true today, with all the new technology and advances
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burden of proof is on them to prove animals are cur-
rently necessary.
6. Regardless of how many breakthroughs of the past
relied on animals, some did and that alone justifies
the use of sentient animals in basic research.
There can be no doubt that some breakthroughs of
the past were incumbent upon sentient animals. How-
ever, this objection does not consider current knowledge
and technology available today that was not available in
the past; the differences between questions asked in the
past and those being asked today; the probability of
finding treatments using sentient animals as opposed to
other modalities; and the value society currently places
on sentient animals as opposed to centuries or even
decades ago.
7. When Thomas Edison was asked about all his fail-
ures in trying to invent a light bulb, he supposedly
said that he had not failed 100 times (or 1000 times,
s o u r c e sv a r yo nt h ee x a c tn u m b e r )b u tt h a th eh a d
succeeded in finding 100 ways that would not work
and that when he had eliminated the ways that
would not work, he will have found the one way
that will work. That is what basic research is.
T h i si sac u t el i t t l es t o r ya n dm i g h te v e nb et r u e
(again sources vary), but it has essentially nothing to do
with our discussion. First, Edison was not spending
resources that society valued beyond their monetary
face value. Society values children more than orange
juice and endangered plants more than those not endan-
gered. Society does have a hierarchy of value. Scientists
can spend resources that are largely of no or very little
value to society, like common chemicals in a beaker, on
the off chance something will result from it. But society
mandates that researchers cannot spend, with impunity,
resources it does value. Society values sentient animals
more than inorganic materials.
Second, Edison was spending his own time and his
own funds, and using resources society did not find to
have inherent value. Therefore, society had essentially
no legitimate grounds for telling Edison what to do with
any of the above. Third, society did not fund Edison
over other options. Fourth, Edison made no promises to
society in exchange for its resources. His failures were
largely irrelevant in that regard.
Alternatives
There is nothing scientifically sacred about using senti-
ent animals in basic research. Nonetheless, whenever we
q u e s t i o nt h ee f f i c a c yo fs u c hu s ew ea r em e tw i t ht h e
inevitable question: “How will we do basic research
without using sentient animals?” Were this question not
posed so seriously, we would suspect cynicism. But the
questioner is serious so we will very briefly outline other
methods available for basic research.
￿ The time-honored study of chemistry and physics
has led to breakthroughs without which today we
would still be practicing medicine circa the 19th
century. Basic research in engineering and the physi-
cal sciences has historically led to advances in
technology.
￿ In vitro research using human tissue.
￿ Bacteria, viruses, and fungi can be studied in order
to discover basic cellular and genetic properties.
Research using nonsentient, less complex organisms
like Drosophila have given us the entire field of evo
devo. As we mentioned, other organisms that could
be studied include E .c o l i ,C .e l e g a n s , Brassica rapa,
Saccharomyces cerevisiae, Phage Phi-X174, Dictyoste-
lium discoideum. This is a very partial list.
￿ Autopsies could be funded as non-goal oriented
research as autopsies have historically led to many
unsought discoveries and facts about the human
body. New knowledge is still being generated by
autopsies [130,131].
￿ The fields of mathematical and computer modeling
offer ways to study complex systems but need
funding.
￿ Basic research using human stem cells.
￿ Another important but oft-overlooked area of
study is evolutionary biology. More emphasis needs
to be placed on the study of evolution, the place of
evolution in disease, and the implications of evolu-
tion for disease research and treatment.
The above is a very partial list. Eliminating the use of
sentient animals in basic research would not lead to a
dearth of basic research that needs funding. Ceasing to
fund basic research using sentient animals would not
help the NIH increase their application-funded to appli-
cation-received ratio.
Conclusion
Sir Ernst Chain, co-discoverer of penicillin, stated in
1970:
Science, as long as it limits itself to the descriptive
study of Nature, has no moral or ethical quality,
and this applies to the physical as well as the biolo-
gical sciences. No quality of good or evil is
attached to results of research aimed at determin-
ing natural constants, such as that of gravity or the
velocity of light, or measuring the movements of
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enzyme, or describing the behaviour of animals
(whatever our emotional attitude towards it may
be) or studying the metabolic activity of a microbe,
whether harmful or beneficial to mankind, or
studying physiological function or pharmacological
and toxic action. No quality of good or evil can be
ascribed to studies aimed at the elucidation [of
such questions] [132].
There can be no doubt that basic research has
resulted in great breakthroughs in physics, chemistry,
and biology. Almost by definition, in the early days of
science, basic research was responsible for many, if not
most, of the great discoveries. Today, we still see basic
research generating a plethora of facts. The question we
have posed is whether the controversial practice of
using sentient animals in basic biomedical research is
justifiable given society’sd i s t r e s sa b o u tu s i n gs u c ha n i -
mals in such ways.
Sir Ernst’s statement must be viewed in light of moral
responsibilities that lie outside of science. Slavery, for
example, is wrong even if slaves were to be used in
scientific pursuits. Other issues also arise when one con-
templates basic research. Philosopher Mary Midgley:
Sanctimonious obsessiveness needs to be publicly
unmasked. It needs to be spelt out why an attempt
understand desertification in Africa in order to resist
it is not, just as such, at some deep level academi-
cally inferior to advance in theoretical physics.
Something needs to be done here about the tenden-
tious current use of words like ‘basic’ and ‘funda-
mental’ to describe any research which is not
intended be useful. Trivial questions are still trivial,
even when their answers are useless. Their useless-
ness cannot of itself transform them into fundamen-
tal ones [133].
Basic research is valuable for its own sake, even when
treatments are not forthcoming. However, this value
must be weighed against 1) other research that could be
funded; 2) the cost, other than financial of performing
the research; and 3) the value society places on sentient
animals, even if society is at times inconsistent in apply-
ing that value.
In conclusion, we have shown that:
1. Society has expressed in open forums and via
well-conducted surveys, its view that sentient ani-
mals should only be used in biomedical research
that is likely to add treatments and cures or decrease
the suffering of human patients. This position has
been acknowledged by respected science journals.
2. Basic research has historically been justified based
on its value in adding new knowledge to the world
not on the basis of decreasing human suffering.
3. In the mid 20th century, this justification was
threatened and researchers responded by connecting
basic research to advances in medical science vis-à-
vis the Comroe Dripps report.
4. Current research reexamining Comroe Dripps and
the contribution of basic research in general to dis-
covering new treatments and cures has revealed that
there currently exists a low probability that basic
research in general will lead to cures for human dis-
ease. This does not contradict the fact that histori-
cally basic science research in general and basic
science research using sentient animals specifically
resulted in breakthroughs in biomedical research.
The times, available methods, and questions have
changed.
5. According to figures from the NIH, basic biome-
dical research receives more funding than all other
forms of research, uses animals more often than not,
and many if not most of these animals would be
classified by society in general as sentient. There is a
high probability that such use will, by the very fact
that the animals will be confined in an unnatural
environment, cause pain and suffering.
Based upon our interpretation of data gained from
research published in peer reviewed journals, public opi-
nion polls, and comments reflecting the aforementioned
in the scientific literature, we conclude that society does
not condone using sentient animals in basic research.
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